Pacific Biosciences (PacBio), headquartered in Menlo Park, CA, is a startup biotechnology company developing a transformative Single Molecule Real Time (SMRT™) DNA sequencing platform. PacBio’s goal is to commercialize SMRT DNA sequencing technology, eventually enabling sequencing of individual genomes as part of routine medical care. The company is currently venture funded by Kleiner Perkins Caufield & Byers, Mohr Davidow Ventures, Alloy Ventures, Maverick Capital, and others.